Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Open in API
Filings indexed 2,743 across all filing types
Latest filing 2025-01-27 Regulatory Filings
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve the Unaudited Consolidated ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for February 3, 2025. The purpose of the meeting is to consider and approve the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2024. The letter references SEBI regulations related to disclosure and insider trading. The document is short (1604 characters) and serves as an announcement of a future event (Board Meeting) rather than containing any financial results or detailed management discussion. It does not contain actual financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories like Interim Report or Earnings Release. It is not a Management Information announcement about board changes (MANG) since it is about a meeting notice, not changes in board composition.
2025-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an intimation letter to stock exchanges about an upcoming Analysts’/Investors Call scheduled for February 3, 2025, to discuss the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2024. It includes details about the conference call, such as timing, dial-in numbers, and contact information. The document does not contain any actual financial data or detailed financial analysis but serves as a notification of the event where such information will be discussed. Therefore, this document is a Call Transcript announcement or invitation rather than the transcript itself. Given the nature of the document as an announcement of the call, the most appropriate classification is Call Transcript (CT).
2025-01-27 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-27 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for February 3, 2025. The purpose of the meeting is to consider and approve the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2024. The letter also mentions the closure of the trading window in compliance with insider trading regulations. The document is short (1604 characters) and serves as an announcement of the Board Meeting and the upcoming financial results, not the financial results report itself. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain actual financial data or detailed report content.
2025-01-27 English
Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It mentions rescheduling of a meeting and provides dates and venues for upcoming investor meetings. There is no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The document is an update on investor relations activities, specifically about meetings with analysts and investors, which fits the description of an Investor Presentation or related communication. However, since it is a schedule notice rather than a detailed presentation, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings under SEBI regulations, not a full investor presentation or report.
2025-01-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides dates and venues for investor meetings. There is no financial data, no report attached or published, and no detailed presentation or analysis included. The document is an announcement about investor meetings, not a financial report, earnings release, or presentation. It is also not a regulatory filing in the sense of officer certifications or compliance documents but rather a notification about scheduled investor interactions. Given the content and context, the best fitting category is Investor Presentation (IP) as it relates to investor meetings and communications, although it is a schedule notice rather than a full presentation. However, since it is specifically about scheduling meetings with analysts and institutional investors, it aligns most closely with Investor Presentation (IP). Confidence is high due to clear references and content type.
2025-01-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.